medigraphic.com
ISSN 1527-3172 (Electronic)

2019, Number 4

<< Back Next >>

MEDICC Review 2019; 21 (4)

Cuban strategy and medical cooperation to combat ebola, 2014-2016

Pérez-Ávila J, Núñez-Monteagudo D, Muné-Jiménez M, Gil-del Valle L, Garcés-Martínez M, Fernández-Llanes R, Somarriba-López L

Language: English
References: 26
Page: 53-58
PDF size: 85.49 Kb.


ABSTRACT

The Ebola virus is a pathogen that causes high morbidity and mortality in epidemic events during which health personnel are frequently infected. Such an epidemic occurred in West Africa, prompting WHO to issue a call in 2014 for health personnel to be dispatched to affected countries. Cuba responded and signed an assistance agreement under which 265 Cuban health professionals, members of the Henry Reeve Emergency Medical Contingent, volunteered their services in the Republic of Guinea, Sierra Leone and Liberia. This article presents Cuba’s strategy of medical aid and organization of the three medical teams formed; refers to the teams’ contribution to epidemic control in treatment centers where they worked alongside other personnel; and describes measures taken in Cuba to prevent the virus from entering the country through returning volunteers or other means. In the centers where Cuban medical teams worked with other health professionals in West Africa, case fatality decreased from 80%–90% to 24%, contributing to control of the epidemic; no Ebola outbreaks occurred in Cuba. During the epidemic, two Cuban health professionals died of malaria and one physician fell ill with Ebola. This paper includes an overview of the treatment and evolution of the latter case, a doctor who contracted the disease in Sierra Leone and was treated in Geneva and Havana.


REFERENCES

  1. Zampieri CA, Sullivan NJ, Nabel GJ. Immunopathology of highly virulent pathogens: insights from Ebola virus. Nat Immunol. 2007 Nov;8(11):1159–64.

  2. Kuzmin IV, Schwarz TM, Ilinykh PA, Jordan I, Ksiazek TG, Sachidanandam R, et al. Innate immune responses of bat and human cells to  loviruses: commonalities and distinctions. J Virol. 2017 Apr 15;91(8).

  3. Singh RK, Dhama K, Malik YS, Ramakrishnan MA, Karthik K, Khandia R, et al. Ebola virus - epidemiology, diagnosis, and control: threat to humans, lessons learnt, and preparedness plans - an update on its 40 year's journey. Vet Q. 2017 Dec;37(1):98–135.

  4. Jiang T, Jiang JF, Deng YQ, Jiang BG, Fan H, Han JF, et al. Features of Ebola virus disease at the late outbreak stage in Sierra Leone: clinical, virological, immunological, and evolutionary analyses. J Infect Dis. 2017 Apr 1;215(7):1107–10.

  5. Deen GF, McDonald SLR, Marrinan JE, Sesay FR, Ervin E, Thorson AE, et al. Implementation of a study to examine the persistence of Ebola virus in the body  uids of Ebola virus disease survivors in Sierra Leone: methodology and lessons learned. PLoS Negl Trop Dis. 2017 Sep 11;11(9):e0005723.

  6. Mérens A, Bigaillon C, Delaune D. Ebola virus disease: biological and diagnostic evolution from 2014 to 2017. Med Mal Infect. 2018 Mar;48(2):83–94.

  7. France Presse. La OMS declara el Ébola "emergencia de salud pública" mundial. El Mundo [Internet]. 2019 Jul 17 [cited 2019 Aug 15];Internacional:[about 2 screens]. Available from: https://www.elmundo.es/internacional/2019/ 07/17/5d2f651ffdddffb9698b46f3.html. Spanish.

  8. Corporación de Radio y TV Españolas Online [Internet]; c2019. Madrid: Radio y Televisión Españolas. Noticias. La Organización Mundial de la Salud (OMS) decreta una alerta mundial por el brote de Ébola;2014 Aug 8 [cited 2019 Aug 21]. Available from: http://www.rtve.es/noticias /20140808/organizacion-mundial-salud-decreta -alerta-mundial-brote-ebola/989502.shtml. Spanish.

  9. Karamouzian M, Hategekimana C. Ebola treatment and prevention are not the only battles: understanding Ebola-related fear and stigma. Int J Health Policy Manag. 2014 Dec 2;4(1):55–6.

  10. Geisbert T, Hensley L, Larsen T, Young H, Reed D, Geisbert J, et al. Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques. Am J Pathol. 2003 Dec;163(6):2347–70.

  11. World Health Organization. Manejo clínico de los pacientes con  ebre hemorrágica: Guía de bolsillo para personal sanitario de primera línea 2014. Geneva: World Health Organization; 2014 Dec.154 p. Spanish.

  12. Carballo Herrera R. Memorias de un enfermero cubano cara a cara con el Ébola en Guinea Conakry. Rev Cubana Enferm. 2018;34(2). Spanish.

  13. Maguina Vargas C. Enfermedad por el virus del Ébola. Rev Med Hered. 2015;26(3):195–201. Spanish.

  14. World Health Organization [Internet]. Geneva: World Health Organization; c2019. Media Center. Dr Lee-Jong-wook Memorial Prize for Public Health 2017; 2017 May 26 [cited 2019 Aug 21]; [about 2 screens]. Available from: https://www .who.int/mediacentre/events/2017/wha70/lee -jong-wook-prize/en/

  15. Ubieta Gómez E. Zona Roja: la experiencia cubana del Ébola. Havana: Editorial Abril; 2016 Apr 1. 254 p. Spanish.

  16. Moekotte AL, Huson MAM, van der Ende AJ, Agnandji ST, Huizenga E, Goorlis A et al. Monoclonal antibodies for the treatment of Ebola virus disease. Expert Opinion Invest Drug [Internet]. 2016 Oct 8 [cited 2019 Aug 22];25(11):1325–35. Available from: https://www.tandfonline.com/doi/ full/10.1080/13543784.2016.1240785

  17. Moneriz C, Zapata S. Avances cientí cos en las estrategias terapéuticas contra la enfermedad por virus del Ébola. Biosalud [Internet]. 2016 Dec [cited 2019 Aug 21];15(2):87–105. Available from: https://temas.sld.cu/ebola/2018/04/05/ avances-cientificos-en-las-estrategias-terapeu ticas-contra-la-enfermedad-por-virus-del-ebola/. Spanish.

  18. Schibler M, Vetter P, Cherpillod P, Petty TJ, Cordey S, Vieille G, et al. Clinical features and viral kinetics in a rapidly cured patient with Ebola virus disease: a case report. Lancet Infect Dis. 2015 Sep;15(9):1034–40.

  19. Núñez Sellés AJ, Guevara García M, Álvarez León A, Pardo Andreu GL. Experiencias de la terapia antioxidante con Vimang en la atención primaria de salud en Cuba. Rev Cubana Salud Pública [Internet]. 2007 Jul–Sep [cited 2019 Agu 22];33(3). Available from: http://scielo.sld .cu/scielo.php?script=sci_arttext&pid=S0864 -34662007000300017&lng=es. Spanish.

  20. Petrosillo N, Nicastri E, Lanini S, Capobianchi M, Caro A, Antonini M, et al. Ebola virus disease complicated with viral interstitial pneumonia: a case report. BMC Infect Dis. 2015 Oct 16;15:432.

  21. Ji YJ, Duan XZ, Gao XD, Li L, Li C, Ji D, et al. Clinical presentations and outcomes of patients with Ebola virus disease in Freetown, Sierra Leone. Infect Dis Poverty. 2016 Nov 3;5(1):101.

  22. Ducharme J. Experimental Ebola Treatments Look Successful in Lab Studies, Says the CDC. TIME [Internet]. 2019 Jul 10 [cited 2019 Aug 22];Health:[about 2 screens]. Available from: https://www.cdc.gov/vhf/ebola/treatment/index .html

  23. Sissoko D, Laouenan C, Folkesson E, M'Lebing AB, Beavogui AH, Baize S, et al. Experimental treatment with favipiravir for Ebola virus disease (the JIKI Trial): ahistorically controlled, single-arm proof-of-concept trial in Guinea. PLoS Med [Internet]. 2016 Mar [cited 2019 Aug 22];13(3):e1001967. Available from: https://www .ncbi.nlm.nih.gov/pmc/articles/PMC4773183/

  24. Napralert Database [Internet]. Illinois: University of Illinois; c2019 [cited 2019 Aug 22]. Available from: http://apps.who.int/medicinedocs/es/m/abs tract/Js21282en/

  25. Kaner J, Schaack S. Understanding Ebola: the 2014 epidemic. Global Health [Internet]. 2016 Sep 13 [cited 2019 Aug 22];12(1):53. Available from: https://globalizationandhealth.biomedcen tral.com/articles/10.1186/s12992-016-0194-4

  26. Liu J. Pushed to the Limit and Beyond: A Year into the Largest Ever Ebola Outbreak. 2015. Médecins Sans Frontières [Internet] 3 de Marzo 2015. [cited 2019 Aug 22]. Available from: http://www.msf.org/ en/article/ebola-pushed-limit-and-beyond




2020     |     www.medigraphic.com